{"count": 11, "results": [{"_id": "37242493", "pmid": 37242493, "pmcid": "PMC10222124", "title": "The Effect of Statins on Ocular Disorders: A Systematic Review of Randomized Controlled Trials", "journal": "Pharmaceuticals (Basel)", "authors": ["Lymperopoulou C", "Kandarakis SA", "Tzanaki I", "Mylona I", "Xanthos T", "Agouridis AP"], "date": "2023-05-07T00:00:00Z", "doi": "10.3390/ph16050711", "meta_date_publication": "2023 May 7", "meta_volume": "16", "meta_issue": "5", "meta_pages": "", "score": 50268.31, "text_hl": "Ten studies investigated the role of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, suggesting a lack of cataractogenic effect and a possible protective role in @<m>DISEASE_Cataract</m> @DISEASE_MESH:D002386 @@@cataract@@@ formation, @DISEASE_Retinal_Diseases @DISEASE_MESH:D012164 @@@retinal vascular diseases@@@, and especially @DISEASE_Diabetic_Retinopathy @DISEASE_MESH:D003930 @@@diabetic retinopathy@@@, @DISEASE_Macular_Degeneration @DISEASE_MESH:D008268 @@@age-related macular disease@@@ progression, and non-infectious @DISEASE_Uveitis @DISEASE_MESH:D014605 @@@uveitis@@@. ", "citations": {"NLM": "Lymperopoulou C, Kandarakis SA, Tzanaki I, Mylona I, Xanthos T, Agouridis AP. The Effect of Statins on Ocular Disorders: A Systematic Review of Randomized Controlled Trials Pharmaceuticals (Basel). 2023 May 7;16(5):. PMID: 37242493", "BibTeX": "@article{37242493, title={The Effect of Statins on Ocular Disorders: A Systematic Review of Randomized Controlled Trials}, author={Lymperopoulou C and Kandarakis SA and Tzanaki I and Mylona I and Xanthos T and Agouridis AP}, journal={Pharmaceuticals (Basel)}, volume={16}, number={5}}"}}, {"_id": "35601076", "pmid": 35601076, "pmcid": "PMC9117960", "title": "Simvastatin alleviates epithelial-mesenchymal transition and oxidative stress of high glucose-induced lens epithelial cells in vitro by inhibiting RhoA/ROCK signaling", "journal": "Exp Ther Med", "authors": ["Fu J", "Hu X"], "date": "2022-06-01T00:00:00Z", "doi": "10.3892/etm.2022.11347", "meta_date_publication": "2022 Jun", "meta_volume": "23", "meta_issue": "6", "meta_pages": "420", "score": 50254.46, "text_hl": "The aim of the present study was to examine the effect of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on lens epithelial cells in @<m>DISEASE_Cataract</m> @DISEASE_MESH:D002386 @@@DC@@@ and the underlying mechanism. ", "citations": {"NLM": "Fu J, Hu X. Simvastatin alleviates epithelial-mesenchymal transition and oxidative stress of high glucose-induced lens epithelial cells in vitro by inhibiting RhoA/ROCK signaling Exp Ther Med. 2022 Jun;23(6):420. PMID: 35601076", "BibTeX": "@article{35601076, title={Simvastatin alleviates epithelial-mesenchymal transition and oxidative stress of high glucose-induced lens epithelial cells in vitro by inhibiting RhoA/ROCK signaling}, author={Fu J and Hu X}, journal={Exp Ther Med}, volume={23}, number={6}, pages={420}}"}}, {"_id": "1951069", "pmid": 1951069, "title": "Long-term safety and efficacy profile of simvastatin.", "journal": "Am J Cardiol", "authors": ["Boccuzzi SJ", "Bocanegra TS", "Walker JF", "Shapiro DR", "Keegan ME"], "date": "1991-11-01T00:00:00Z", "doi": "10.1016/0002-9149(91)90182-k", "meta_date_publication": "1991 Nov 1", "meta_volume": "68", "meta_issue": "11", "meta_pages": "1127-31", "score": 50067.52, "text_hl": "Long-term safety and efficacy profile of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@.", "citations": {"NLM": "Boccuzzi SJ, Bocanegra TS, Walker JF, Shapiro DR, Keegan ME. Long-term safety and efficacy profile of simvastatin. Am J Cardiol. 1991 Nov 1;68(11):1127-31. PMID: 1951069", "BibTeX": "@article{1951069, title={Long-term safety and efficacy profile of simvastatin.}, author={Boccuzzi SJ and Bocanegra TS and Walker JF and Shapiro DR and Keegan ME}, journal={Am J Cardiol}, volume={68}, number={11}, pages={1127-31}}"}}, {"_id": "11525705", "pmid": 11525705, "title": "Risk of cataract in patients treated with statins.", "journal": "Arch Intern Med", "authors": ["Schlienger RG", "Haefeli WE", "Jick H", "Meier CR"], "date": "2001-09-10T00:00:00Z", "doi": "10.1001/archinte.161.16.2021", "meta_date_publication": "2001 Sep 10", "meta_volume": "161", "meta_issue": "16", "meta_pages": "2021-6", "score": 50066.04, "text_hl": "CONCLUSIONS: Our study provides evidence that long-term use of therapeutic statin doses does not increase the risk of developing @<m>DISEASE_Cataract</m> @DISEASE_MESH:D002386 @@@cataract@@@. Concomitant use of @CHEMICAL_Erythromycin @CHEMICAL_MESH:D004917 @@@erythromycin@@@ and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ may increase the @<m>DISEASE_Cataract</m> @DISEASE_MESH:D002386 @@@cataract@@@ risk.", "citations": {"NLM": "Schlienger RG, Haefeli WE, Jick H, Meier CR. Risk of cataract in patients treated with statins. Arch Intern Med. 2001 Sep 10;161(16):2021-6. PMID: 11525705", "BibTeX": "@article{11525705, title={Risk of cataract in patients treated with statins.}, author={Schlienger RG and Haefeli WE and Jick H and Meier CR}, journal={Arch Intern Med}, volume={161}, number={16}, pages={2021-6}}"}}, {"_id": "2080693", "pmid": 2080693, "title": "Lens changes in matched normals and hyperlipidemic patients treated with simvastatin for 2 years.", "journal": "Acta Ophthalmol (Copenh)", "authors": ["Lundh BL", "Nilsson SE"], "date": "1990-12-01T00:00:00Z", "doi": "10.1111/j.1755-3768.1990.tb01689.x", "meta_date_publication": "1990 Dec", "meta_volume": "68", "meta_issue": "6", "meta_pages": "658-60", "score": 50061.586, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@, a potent blood lipid reducer, has been suspected of inducing @<m>DISEASE_Cataract</m> @DISEASE_MESH:D002386 @@@cataract@@@ in @SPECIES_9615 @@@dogs@@@. ", "citations": {"NLM": "Lundh BL, Nilsson SE. Lens changes in matched normals and hyperlipidemic patients treated with simvastatin for 2 years. Acta Ophthalmol (Copenh). 1990 Dec;68(6):658-60. PMID: 2080693", "BibTeX": "@article{2080693, title={Lens changes in matched normals and hyperlipidemic patients treated with simvastatin for 2 years.}, author={Lundh BL and Nilsson SE}, journal={Acta Ophthalmol (Copenh)}, volume={68}, number={6}, pages={658-60}}"}}, {"_id": "2679082", "pmid": 2679082, "title": "Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors.", "journal": "Am J Med", "authors": ["Gerson RJ", "MacDonald JS", "Alberts AW", "Kornbrust DJ", "Majka JA", "Stubbs RJ", "Bokelman DL"], "date": "1989-10-16T00:00:00Z", "doi": "10.1016/s0002-9343(89)80596-0", "meta_date_publication": "1989 Oct 16", "meta_volume": "87", "meta_issue": "4A", "meta_pages": "28S-38S", "score": 50061.125, "text_hl": "The data suggest that the development of @<m>DISEASE_Cataract</m> @DISEASE_MESH:D002386 @@@lenticular opacities@@@ at clinical doses of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ is highly improbable. ", "citations": {"NLM": "Gerson RJ, MacDonald JS, Alberts AW, Kornbrust DJ, Majka JA, Stubbs RJ, Bokelman DL. Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors. Am J Med. 1989 Oct 16;87(4A):28S-38S. PMID: 2679082", "BibTeX": "@article{2679082, title={Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors.}, author={Gerson RJ and MacDonald JS and Alberts AW and Kornbrust DJ and Majka JA and Stubbs RJ and Bokelman DL}, journal={Am J Med}, volume={87}, number={4A}, pages={28S-38S}}"}}, {"_id": "12518039", "pmid": 12518039, "title": "Discordant expression of the sterol pathway in lens underlies simvastatin-induced cataracts in Chbb: Thom rats.", "journal": "J Lipid Res", "authors": ["Cenedella RJ", "Kuszak JR", "Al-Ghoul KJ", "Qin S", "Sexton PS"], "date": "2003-01-01T00:00:00Z", "doi": "10.1194/jlr.m200002-jlr200", "meta_date_publication": "2003 Jan", "meta_volume": "44", "meta_issue": "1", "meta_pages": "198-211", "score": 50060.54, "text_hl": "Discordant expression of the @CHEMICAL_Sterols @CHEMICAL_MESH:D013261 @@@sterol@@@ pathway in lens underlies @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-induced @<m>DISEASE_Cataract</m> @DISEASE_MESH:D002386 @@@cataracts@@@ in Chbb: Thom @SPECIES_10116 @@@rats@@@.", "citations": {"NLM": "Cenedella RJ, Kuszak JR, Al-Ghoul KJ, Qin S, Sexton PS. Discordant expression of the sterol pathway in lens underlies simvastatin-induced cataracts in Chbb: Thom rats. J Lipid Res. 2003 Jan;44(1):198-211. PMID: 12518039", "BibTeX": "@article{12518039, title={Discordant expression of the sterol pathway in lens underlies simvastatin-induced cataracts in Chbb: Thom rats.}, author={Cenedella RJ and Kuszak JR and Al-Ghoul KJ and Qin S and Sexton PS}, journal={J Lipid Res}, volume={44}, number={1}, pages={198-211}}"}}, {"_id": "31669197", "pmid": 31669197, "title": "Cataracts and statins. A disproportionality analysis using data from VigiBase.", "journal": "Regul Toxicol Pharmacol", "authors": ["Macías Saint-Gerons D", "Bosco Cortez F", "Jiménez López G", "Castro JL", "Tabarés-Seisdedos R"], "date": "2019-12-01T00:00:00Z", "doi": "10.1016/j.yrtph.2019.104509", "meta_date_publication": "2019 Dec", "meta_volume": "109", "meta_issue": "", "meta_pages": "104509", "score": 50057.004, "text_hl": "@<m>DISEASE_Cataract</m> @DISEASE_MESH:D002386 @@@Cataracts@@@ and statins. A disproportionality analysis using data from VigiBase.", "citations": {"NLM": "Macías Saint-Gerons D, Bosco Cortez F, Jiménez López G, Castro JL, Tabarés-Seisdedos R. Cataracts and statins. A disproportionality analysis using data from VigiBase. Regul Toxicol Pharmacol. 2019 Dec;109():104509. PMID: 31669197", "BibTeX": "@article{31669197, title={Cataracts and statins. A disproportionality analysis using data from VigiBase.}, author={Macías Saint-Gerons D and Bosco Cortez F and Jiménez López G and Castro JL and Tabarés-Seisdedos R}, journal={Regul Toxicol Pharmacol}, volume={109}, pages={104509}}"}}, {"_id": "26602073", "pmid": 26602073, "title": "Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).", "journal": "Am J Cardiol", "authors": ["Bang CN", "Greve AM", "La Cour M", "Boman K", "Gohlke-Bärwolf C", "Ray S", "Pedersen T", "Rossebø A", "Okin PM", "Devereux RB", "Wachtell K"], "date": "2015-12-15T00:00:00Z", "doi": "10.1016/j.amjcard.2015.09.026", "meta_date_publication": "2015 Dec 15", "meta_volume": "116", "meta_issue": "12", "meta_pages": "1840-4", "score": 50051.86, "text_hl": "In conclusion, randomized treatment with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ plus @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ was associated with a 44% lower risk of incident @<m>DISEASE_Cataract</m> @DISEASE_MESH:D002386 @@@cataract@@@ development. ", "citations": {"NLM": "Bang CN, Greve AM, La Cour M, Boman K, Gohlke-Bärwolf C, Ray S, Pedersen T, Rossebø A, Okin PM, Devereux RB, Wachtell K. Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study). Am J Cardiol. 2015 Dec 15;116(12):1840-4. PMID: 26602073", "BibTeX": "@article{26602073, title={Effect of Randomized Lipid Lowering With Simvastatin and Ezetimibe on Cataract Development (from the Simvastatin and Ezetimibe in Aortic Stenosis Study).}, author={Bang CN and Greve AM and La Cour M and Boman K and Gohlke-Bärwolf C and Ray S and Pedersen T and Rossebø A and Okin PM and Devereux RB and Wachtell K}, journal={Am J Cardiol}, volume={116}, number={12}, pages={1840-4}}"}}, {"_id": "16110301", "pmid": 16110301, "title": "Concentration and distribution of ubiquinone (coenzyme Q), the endogenous lipid antioxidant, in the rat lens: effect of treatment with simvastatin.", "journal": "Mol Vis", "authors": ["Cenedella RJ", "Neely AR", "Sexton P"], "date": "2005-08-10T00:00:00Z", "meta_date_publication": "2005 Aug 10", "meta_volume": "11", "meta_issue": "", "meta_pages": "594-602", "score": 50045.86, "text_hl": "Sprague-Dawley (SD) and Chbb:Thom (CT) @SPECIES_10116 @@@rats@@@ were treated with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, an inducer of @<m>DISEASE_Cataract</m> @DISEASE_MESH:D002386 @@@cataracts@@@ in CT @SPECIES_10116 @@@rats@@@, to determine its effects on lens Ubs. ", "citations": {"NLM": "Cenedella RJ, Neely AR, Sexton P. Concentration and distribution of ubiquinone (coenzyme Q), the endogenous lipid antioxidant, in the rat lens: effect of treatment with simvastatin. Mol Vis. 2005 Aug 10;11():594-602. PMID: 16110301", "BibTeX": "@article{16110301, title={Concentration and distribution of ubiquinone (coenzyme Q), the endogenous lipid antioxidant, in the rat lens: effect of treatment with simvastatin.}, author={Cenedella RJ and Neely AR and Sexton P}, journal={Mol Vis}, volume={11}, pages={594-602}}"}}]}